Generic Name: polyethylene glycol 3350
Dosage Form: powder, for solution
MiraLAX®
Polyethylene Glycol 3350
Powder for Solution, Osmotic Laxative
Drug Facts
Active ingredient (in each dose)
Polyethylene Glycol 3350, 17 g
Purpose
Osmotic Laxative
Use
- relieves occasional constipation (irregularity)
- generally produces a bowel movement in 1 to 3 days
Warnings
Allergy alert
Do not use if you are allergic to polyethylene glycol
Do not use if you have kidney disease, except under the advice and supervision of a doctor
Ask a doctor before use if you have
- nausea, vomiting or abdominal pain
- a sudden change in bowel habits that lasts over 2 weeks
- irritable bowel syndrome
Ask a doctor of pharmacist before use if you are taking a prescription drug
When using this product you may have loose, watery, more frequent stools
Stop use and ask a doctor if
- you have rectal bleeding or you nausea, bloating or cramping or abdominal pain gets worse. These may be signs of a serious condition.
- you get diarrhea
- you need to use a laxative for longer than 1 week
If pregnant or breast-feeding, ask a health professional before use.
Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
- do not take more than directed unless advised by your doctor
- adults and children 17 years of age and older:
- stir and dissolve one packet of powder (17 g) in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink
- use once a day
- use no more than 7 days
- children 16 years of age or under: ask a doctor
Other information
- store at 20°-25°C (68°-77°F)
- tamper-evident: do not use if foil is open or broken
Inactive ingredients
none
Questions or comments?
1-800-MiraLAX (1-800-647-2529) or www.MiraLAX
PRINCIPAL DISPLAY PANEL - 17g Packet Carton
10 Packets
NDC 11523-7268-3
Original
Prescription
Strength
MiraLAX®
Polyethylene Glycol 3350
Powder for Solution, Osmotic Laxative
NeatPAX™
Travel Size
- Relieves Occasional
Constipation
(Irregularity) - Softens Stool
10 PACKETS
EACH PACKET NET WT 0.5 OZ (17g)
10
ONCE-DAILY DOSES
MiraLAX polyethylene glycol 3350 powder, for solution | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA | NDA022015 | 02/23/2009 |
Labeler - Schering-Plough HealthCare Products, Inc. (039137567) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Schering Corporation | 155914674 | MANUFACTURE |
Establishment | |||
Name | Address | ID/FEI | Operations |
Catalent Pharma Solutions | 806746405 | PACK, LABEL |
More MiraLAX resources
- MiraLAX Side Effects (in more detail)
- MiraLAX Use in Pregnancy & Breastfeeding
- MiraLAX Drug Interactions
- MiraLAX Support Group
- 27 Reviews for MiraLAX - Add your own review/rating
- MiraLax Concise Consumer Information (Cerner Multum)
- MiraLax Powder for Oral Solution MedFacts Consumer Leaflet (Wolters Kluwer)
Compare MiraLAX with other medications
- Bowel Preparation
- Constipation
- Constipation, Acute
No comments:
Post a Comment